Identification of a new bisindolinone arresting IGROV1 cells proliferation

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Novel Knoevenagel adducts were screened for antitumor activity.
• Compound 5f demonstrated significant selectivity against the IGROV1 ovarian cancer cell line.
• The compound did not affect healthy human fibroblast cells, indicating a favorable safety profile.

Purpose of the Study:

• To investigate the detailed antitumor properties of compound 5f.
• To elucidate the molecular mechanisms underlying its efficacy.
• To evaluate its potential as a targeted ovarian cancer therapeutic.

Main Methods:

• Cytotoxicity assays
• Cell proliferation and migration assays
• Analysis of epigenetic modifications (histone acetylation)
• Gene expression analysis (cyclin D1, integrin β1)
• Assessment of DNA damage and radiosensitization

Main Results:

• Compound 5f induced proliferation arrest and decreased cell motility in IGROV1 cells.
• It caused histone hyperacetylation and downregulated the transcription of cyclin D1 and the α5 subunit of integrin β1.
• 5f treatment reduced both transcript and protein levels of cyclin D1.
• The compound increased sensitivity to ionizing radiation, leading to DNA damage.

Conclusions:

• Compound 5f exhibits potent and selective antitumor activity against ovarian cancer cells.
• Its mechanism involves inhibiting proliferation, reducing motility, and modulating gene expression, particularly cyclin D1.
• 5f enhances cancer cell radiosensitivity, suggesting potential in combination therapy for ovarian cancer.